Pharma-Bio Serv (PBSV) Shares Outstanding (Weighted Average) (2016 - 2026)
Pharma-Bio Serv's Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $22.9 million for Q1 2026.
- For Q1 2026, Shares Outstanding (Weighted Average) changed 0.23% year-over-year to $22.9 million; the TTM value through Jan 2026 reached $22.9 million, changed 0.23%, while the annual FY2025 figure was $22.9 million, 0.08% changed from the prior year.
- Shares Outstanding (Weighted Average) reached $22.9 million in Q1 2026 per PBSV's latest filing, roughly flat from $22.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $23.0 million in Q4 2022 to a low of $22.9 million in Q1 2026.
- Average Shares Outstanding (Weighted Average) over 5 years is $23.0 million, with a median of $23.0 million recorded in 2024.
- Peak YoY movement for Shares Outstanding (Weighted Average): fell 0.31% in 2022, then increased 0.08% in 2024.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $23.0 million in 2022, then dropped by 0.14% to $23.0 million in 2023, then dropped by 0.02% to $23.0 million in 2024, then dropped by 0.08% to $22.9 million in 2025, then dropped by 0.18% to $22.9 million in 2026.
- Per Business Quant, the three most recent readings for PBSV's Shares Outstanding (Weighted Average) are $22.9 million (Q1 2026), $22.9 million (Q4 2025), and $22.9 million (Q3 2025).